Author

Yanli Xu

Capital Medical University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Approach:experimental assay· 1

Frequent Co-Authors

Ayijiang YisimayiiD· 2 shared Fanchong JianiD· 2 shared Ronghua JiniD· 2 shared Weiliang Song· 2 shared Xiaosu CheniD· 2 shared Youchun WangiD· 2 shared Yuanling YuiD· 2 shared Yunlong CaoiD· 2 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 44 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Ayijiang YisimayiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Omicron-specific naive B cell maturation alleviates immune imprinting induced by SARS-CoV-2 inactivated vaccine

Ayijiang Yisimayi, Weiliang Song, Jing Wang, Fanchong Jian, Yuanling Yu, Xiaosu Chen, Yanli Xu, Ran An, Yao Wang, Sun Haiyan, Peng Wang, Lingling Yu, Fei Shao, Ronghua Jin, Zhongyang Shen, , Yunlong Cao

The paper investigates how Omicron-specific naive B cell maturation after breakthrough infection alleviates immune imprinting from inactivated SARS-CoV-2 vaccines.

Emerging Microbes & Infections · Oct 3, 2024Peer-reviewedImmunology

Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1

Fanchong Jian, Jing Wang, Ayijiang Yisimayi, Weiliang Song, Yanli Xu, Xiaosu Chen, Xiao Niu, Sijie Yang, Yuanling Yu, Peng Wang, Haiyan Sun, Lingling Yu, Yao Wang, Ran An, Wenjing Wang, , Yunlong Cao

This study analyzes the humoral immune response to SARS-CoV-2 XBB and JN.1 lineages, showing JN.1 elicits superior neutralization and highlights the need for JN.1-based vaccine boosters.

bioRxiv · Apr 19, 2024Immunology